Literature DB >> 17089188

Increased activity and expression of gelatinases in ischemic colitis.

Carlos Medina1, Alfredo Santana, Maria Cristina Paz-Cabrera, Adolfo Parra-Blanco, David Nicolás, Antonio Z Gimeno-Garcia, Enrique Quintero.   

Abstract

Ischemic colitis results from insufficient blood supply but its pathogenesis is poorly understood. The aim of this study was to determine whether the activity and expression of gelatinases (MMP-9 and MMP-2) are increased in the colonic mucosa of patients with ischemic colitis. MMP-9 and MMP-2 activity and expression were assessed in colonic mucosal specimens from 8 patients with acute ischemic colitis and in 12 controls with a normal colonoscopy. The activity and expression of MMP-9 and MMP-2 were quantified in tissue samples by zymography and western blot, respectively. Colonoscopy was repeated 12 weeks after discharge in two patients and MMP activity was assessed in the slight residual mucosal changes of ischemic colitis. In patients with ischemic colitis, a significant increase in total MMP-9 and MMP-2 activity and expression was found in ulcerated areas compared with noninvolved sites of mucosa. Following resolution of ischemic ulcers the proteolytic activity returned to baseline levels. In addition, the colonic mucosa of controls showed MMP-2 activity, whereas the MMP-9 activity was negligible or not detected. We conclude that ischemic colitis induces increased activity and expression of MMP-9 and MMP-2 in the involved colonic mucosa. These changes may contribute to tissue degradation and remodeling of the colonic mucosa in ischemic colitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17089188     DOI: 10.1007/s10620-006-9255-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  34 in total

1.  The individual regulation of granule protein mRNA levels during neutrophil maturation explains the heterogeneity of neutrophil granules.

Authors:  J B Cowland; N Borregaard
Journal:  J Leukoc Biol       Date:  1999-12       Impact factor: 4.962

Review 2.  The matrix-degrading metalloproteinases.

Authors:  L M Matrisian
Journal:  Bioessays       Date:  1992-07       Impact factor: 4.345

3.  Literature on vertebrate matrix metalloproteinases and their tissue inhibitors.

Authors:  J F Woessner
Journal:  Matrix Suppl       Date:  1992

Review 4.  Matrix metalloproteinases and their inhibitors in connective tissue remodeling.

Authors:  J F Woessner
Journal:  FASEB J       Date:  1991-05       Impact factor: 5.191

5.  A major role for matrix metalloproteinases in T cell injury in the gut.

Authors:  S L Pender; S P Tickle; A J Docherty; D Howie; N C Wathen; T T MacDonald
Journal:  J Immunol       Date:  1997-02-15       Impact factor: 5.422

6.  Matrix metalloproteinase levels are elevated in inflammatory bowel disease.

Authors:  M D Baugh; M J Perry; A P Hollander; D R Davies; S S Cross; A J Lobo; C J Taylor; G S Evans
Journal:  Gastroenterology       Date:  1999-10       Impact factor: 22.682

7.  Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations.

Authors:  M Vaalamo; M L Karjalainen-Lindsberg; P Puolakkainen; J Kere; U Saarialho-Kere
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

8.  Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction.

Authors:  A Ducharme; S Frantz; M Aikawa; E Rabkin; M Lindsey; L E Rohde; F J Schoen; R A Kelly; Z Werb; P Libby; R T Lee
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

9.  Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease.

Authors:  R B Heuschkel; T T MacDonald; G Monteleone; M Bajaj-Elliott; J A Smith; S L Pender
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

10.  Collagenase-1 (MMP-1), matrilysin-1 (MMP-7), and stromelysin-2 (MMP-10) are expressed by migrating enterocytes during intestinal wound healing.

Authors:  M T Salmela; S L F Pender; M-L Karjalainen-Lindsberg; P Puolakkainen; T T Macdonald; U Saarialho-Kere
Journal:  Scand J Gastroenterol       Date:  2004-11       Impact factor: 2.423

View more
  4 in total

1.  Inhibition of matrix metalloproteinase-9 by a barbiturate-nitrate hybrid ameliorates dextran sulphate sodium-induced colitis: effect on inflammation-related genes.

Authors:  Shane O'Sullivan; Jun Wang; Maria T Pigott; Neil Docherty; Noreen Boyle; Samuel Kana Lis; John F Gilmer; Carlos Medina
Journal:  Br J Pharmacol       Date:  2017-02-24       Impact factor: 8.739

2.  Serum Cyclophilin A Correlates with Increased Tissue MMP-9 in Patients with Ulcerative Colitis, but Not with Crohn's Disease.

Authors:  Aleksandra Piechota-Polanczyk; Marcin Włodarczyk; Aleksandra Sobolewska-Włodarczyk; Mateusz Jonakowski; Andrzej Pilarczyk; Krystyna Stec-Michalska; Maria Wiśniewska-Jarosińska; Jakub Fichna
Journal:  Dig Dis Sci       Date:  2017-04-08       Impact factor: 3.199

Review 3.  Matrix metalloproteinases in inflammatory bowel disease: an update.

Authors:  Shane O'Sullivan; John F Gilmer; Carlos Medina
Journal:  Mediators Inflamm       Date:  2015-04-08       Impact factor: 4.711

4.  Lack of MMP10 exacerbates experimental colitis and promotes development of inflammation-associated colonic dysplasia.

Authors:  Felicitas L Koller; E Ashley Dozier; Ki Taek Nam; Mei Swee; Timothy P Birkland; William C Parks; Barbara Fingleton
Journal:  Lab Invest       Date:  2012-10-08       Impact factor: 5.662

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.